Option Care Health, Inc. Provides Earnings Guidance for the Fourth Quarter, Full Year 2024 and 2025
January 13, 2025 at 07:05 am EST
Share
Option Care Health, Inc. provided earnings guidance for the Fourth Quarter, Full Year 2024 and 2025. For the quarter, the company expects Net revenue of approximately $1.34 billion to $1.35 billion, representing approximately 19.2% to 20.1% growth over the fourth quarter of 2023. Net income of approximately $56.8 to $60.9 million, or diluted earnings per share of $0.33 to $0.36.
For the full year 2024, the company expects Net revenue of approximately $4.99 billion to $5.00 billion, representing approximately 16.0% to 16.2% growth over the prior year. Net income of approximately $208.5 million to $212.6 million, or diluted earnings per share of $1.21 to $1.23.
For the full year 2025, the company expects Net revenue of $5.2 billion to $5.4 billion.
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Companyâs infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, and others. The Companyâs home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patientâs condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.